Navigation Links
Researchers compare different systems of measuring treatment intensity in hypertension care
Date:6/17/2009

(Boston)- It is known that more intensive management of hypertension can improve blood pressure control and thus improve cardiovascular outcomes. However, there are several different systems of measuring the intensity of management of hypertension, and they have not been previously compared. If one system performs best, it would be important to use it to measure intensity of management for research and quality improvement purposes. Researchers from Boston University have compared different measures of treatment intensity in hypertension care and have found that one of the measures should be preferred to the others. This study, which appears in the July issue of Circulation: Cardiovascular Quality and Outcomes, shows that the measure originally described by Okonofua, et al. (Hypertension, 2006) predicts blood pressure control more effectively than the other two measures studied.

Eight hundred nineteen hypertensive outpatients were characterized with three different scores to measure treatment intensity over time. The first examined whether a patient had any-or-none medication increases. The second approach was a norm-based method, which models the chance of a medication increase at each visit and then scores each patient based on whether they received more or fewer medication increases then predicted. The third approach was a standard-based method, which is similar to the norm-based method, but expects a medication increase whenever the blood pressure is uncontrolled. The researchers compared whether these three scores could predict the final systolic blood pressure and discovered that the any-or-none medication increase and the norm-based measure did not predict blood pressure, and, therefore are not valid measures of treatment intensity. However, they did find that the standard-based measure was an excellent predictor of blood pressure control.

"The norm-based method did not predict systolic blood pressure in a linear fashion. Further investigation revealed a U-shaped relationship between the norm-based score and systolic blood pressure," said lead author Adam Rose, MD, MSc, assistant professor of Medicine at BUSM and investigator at the Bedford VA Medical Center. "In contrast, the standard-based score was an excellent predictor of the final blood pressure, both in the overall population and in every subgroup that was examined. Many research and quality improvement efforts already measure or are proposing to measure treatment intensity in the care of chronic conditions, including diabetes, hypertension and hyperlipidemia."

This study is important to researchers who measure treatment intensity in the care of chronic conditions and healthcare systems that wish to measure treatment intensity for quality improvement or pay for performance programs. This study suggests that, at least with regard to hypertension care, the standard-based score should be the preferred measure.


'/>"/>

Contact: Allison Rubin
allison.rubin@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Jackson, Rockefeller obesity researchers share Shaw Prize
2. TGen and USC researchers find genetic markers to help fight diabetes
3. Vanderbilt researchers pioneer an advanced sepsis detection and management system
4. USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
5. Researchers identify 4 new targets for breast cancer
6. Researchers at Case Western Reserve discover a new way the body fights fungal infection
7. Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
8. Researchers identify four new targets for breast cancer
9. VBI researchers develop new method for breast cancer biomarker discovery
10. Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers
11. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: